Pharmafile Logo

Lexington Health

Lexington Health is a dedicated practice within Lexington Communications with specialist knowledge of healthcare communications and engagement. Our team combines extensive expertise in health policy and campaigns as well as press and digital communication, backed by senior counselling skills honed in our role as strategic advisers to leading global corporations and organisations. Our clients include major blue-chip companies, trade unions, campaign and patient advocacy groups and charities. Lexington Health’s knowledge and experience in strategic communications, and our detailed understanding of the healthcare, biopharmaceutical and medical technologies landscape, enables us to assist clients in dealing with the difficult and complex issues facing their organisations. We understand the need for concise, consistent and coherent communications and engagement and help our clients to secure maximum coverage for their messages among policymakers, politicians, the media, patient groups, clinicians, the public and wider stakeholder groups. Lexington Health also works at an international level, supporting clients across the globe. We have coordinated various campaigns not only in Europe but have also coordinated projects spanning different continents.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

The Connection 198 High Holborn, London, WC1V 7BD

 Latest Content from PMHub 

Supporting Blood Cancer Patients: The Importance of Patient-Centric Pharma Campaigns

White Papers and Resources | September 27, 2024 | Mednet

This Blood Cancer Awareness Month, we want to highlight the critical role of patient-centricity in building awareness, understanding, and support for those living with blood cancers.

Advantages of Virtual Collaboration – Perks of Virtual Medical Education

Videos and Podcasts | September 26, 2024 | Impetus Digital

From extended reach and enhanced interactivity to increased speed and flexibility, learn why virtual settings are becoming a staple in education and professional interaction. Embrace the future of collaboration today!

Driving behaviour change for positive patient outcomes in pharma

Press Releases | September 25, 2024 | Graphite Digital

Discover how pharma can help to achieve better patient health outcomes by informing patient behaviour through insights, strategy and collaboration.

How Design Systems enable streamlined regulatory approval in digital pharma

Press Releases | September 25, 2024 | Graphite Digital

The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...

What is willingness to pay? – Comparing price testing methodologies

Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of willingness to pay (WTP) and what it means for pharmaceutical and medtech pricing strategy. Read on to...

Unlock the Future of Medical Publications—Next Week!

Press Releases | September 19, 2024 | Impetus Digital

Dive into a comprehensive exploration of the latest trends and cutting-edge strategies in medical publication planning. Our exclusive webinar series, starting next week, offers a deep dive into the intricacies...

Innovative Trials’ CEO wins Women in Pharma Award

Press Releases | September 19, 2024 | Innovative Trials

Kate Shaw, founder and CEO of Innovative Trials, a global clinical trial patient recruitment and retention company, won the ‘Woman in Pharma’ at the Pharma Industry Awards UK. She was...

Where did “KOLs” come from, and why do they matter?

White Papers and Resources | September 19, 2024 | Mednet

Ever wondered where 'KOLs' came from and why they matter? Dr Alex Loveday answers those questions in this latest edition of her column.